Gateway Investment Advisers LLC Increases Stock Holdings in Molina Healthcare, Inc. (NYSE:MOH)

Gateway Investment Advisers LLC raised its stake in shares of Molina Healthcare, Inc. (NYSE:MOH) by 0.7% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 19,798 shares of the company’s stock after purchasing an additional 131 shares during the quarter. Gateway Investment Advisers LLC’s holdings in Molina Healthcare were worth $6,822,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in MOH. Innealta Capital LLC bought a new position in Molina Healthcare in the second quarter worth about $36,000. Ashton Thomas Private Wealth LLC purchased a new position in shares of Molina Healthcare in the 2nd quarter valued at approximately $40,000. AM Squared Ltd bought a new stake in shares of Molina Healthcare during the second quarter valued at approximately $59,000. UMB Bank n.a. grew its stake in Molina Healthcare by 96.2% in the third quarter. UMB Bank n.a. now owns 206 shares of the company’s stock worth $71,000 after purchasing an additional 101 shares during the period. Finally, Mather Group LLC. bought a new position in Molina Healthcare in the first quarter worth $123,000. 98.50% of the stock is currently owned by institutional investors.

Molina Healthcare Stock Performance

Shares of MOH stock opened at $330.12 on Friday. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.49. The company has a 50 day moving average price of $342.04 and a 200-day moving average price of $335.67. Molina Healthcare, Inc. has a 52 week low of $282.96 and a 52 week high of $423.92. The firm has a market capitalization of $19.35 billion, a PE ratio of 17.91, a P/E/G ratio of 1.15 and a beta of 0.58.

Molina Healthcare (NYSE:MOH) last announced its earnings results on Wednesday, July 24th. The company reported $5.86 earnings per share for the quarter, beating analysts’ consensus estimates of $5.73 by $0.13. The business had revenue of $9.88 billion during the quarter, compared to analyst estimates of $9.75 billion. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. The company’s quarterly revenue was up 18.7% compared to the same quarter last year. During the same period in the previous year, the business earned $5.65 EPS. As a group, equities research analysts expect that Molina Healthcare, Inc. will post 23.5 earnings per share for the current year.

Insider Activity at Molina Healthcare

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the firm’s stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total value of $339,210.00. Following the transaction, the director now directly owns 18,025 shares of the company’s stock, valued at approximately $6,114,260.25. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, Director Steven J. Orlando sold 1,000 shares of the company’s stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total value of $339,210.00. Following the completion of the sale, the director now directly owns 18,025 shares in the company, valued at $6,114,260.25. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CAO Maurice Hebert sold 393 shares of the business’s stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $346.52, for a total value of $136,182.36. Following the sale, the chief accounting officer now directly owns 9,473 shares of the company’s stock, valued at $3,282,583.96. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.10% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on MOH. Stephens reaffirmed an “equal weight” rating and issued a $320.00 target price on shares of Molina Healthcare in a research report on Thursday, July 25th. JPMorgan Chase & Co. decreased their target price on shares of Molina Healthcare from $420.00 to $395.00 and set an “overweight” rating for the company in a research note on Wednesday, July 10th. Truist Financial dropped their price target on Molina Healthcare from $440.00 to $400.00 and set a “buy” rating on the stock in a research report on Monday, July 15th. TD Cowen reduced their price objective on Molina Healthcare from $412.00 to $351.00 and set a “buy” rating for the company in a research report on Wednesday, July 24th. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on Molina Healthcare from $354.00 to $353.00 and set a “hold” rating on the stock in a report on Monday, July 29th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Molina Healthcare has a consensus rating of “Hold” and a consensus target price of $378.00.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.